KCTD1 and rectum adenocarcinoma: This experimental scenario coupled with the observation here reported of the downregulation and upregulation of KCTD1 and β-catenin expression, respectively, in patients with colon and rectum adenocarcinoma is suggestive of the role of KCTD1 as a potential oncosuppressor in these types of cancers.